Now showing items 1-1 of 1

    • Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium 

      Johnatty, S. E.; Tyrer, J. P.; Kar, S.; Beesley, J.; Lu, Y.; Gao, B.; Fasching, P. A.; Hein, A.; Ekici, A. B.; Beckmann, M. W.; Lambrechts, D.; Van Nieuwenhuysen, E.; Vergote, I.; Lambrechts, S.; Rossing, M. A.; Doherty, J. A.; Chang-Claude, J.; Modugno, F.; Ness, R. B.; Moysich, K. B.; Levine, D. A.; Kiemeney, L. A.; Massuger, L. F. A. G.; Gronwald, J.; Lubinski, J.; Jakubowska, A.; Cybulski, C.; Brinton, L.; Lissowska, J.; Wentzensen, N.; Song, H.; Rhenius, V.; Campbell, I.; Eccles, D.; Sieh, W.; Whittemore, A. S.; McGuire, V.; Rothstein, J. H.; Sutphen, R.; Anton-Culver, H.; Ziogas, A.; Gayther, S. A.; Gentry-Maharaj, A.; Menon, U.; Ramus, S. J.; Pearce, C. L.; Pike, M. C.; Stram, D. O.; Wu, A. H.; Kupryjanczyk, J.; Dansonka-Mieszkowska, A.; Rzepecka, I. K.; Spiewankiewicz, B.; Goodman, M. T.; Wilkens, L. R.; Carney, M. E.; Thompson, P. J.; Heitz, F.; du Bois, A.; Schwaab, I.; Harter, P.; Pisterer, J.; Hillemanns, P.; Karlan, B. Y.; Walsh, C.; Lester, J.; Orsulic, S.; Winham, S. J.; Earp, M.; Larson, M. C.; Fogarty, Z. C.; Hogdall, E.; Jensen, A.; Kjaer, S. K.; Fridley, B. L.; Cunningham, J. M.; Vierkant, R. A.; Schildkraut, J. M.; Iversen, E. S.; Terry, Kathryn Lynne; Cramer, Daniel William; Bandera, E. V.; Orlow, I.; Pejovic, T.; Bean, Y.; Hogdall, C.; Lundvall, L.; McNeish, I.; Paul, J.; Carty, K.; Siddiqui, N.; Glasspool, R.; Sellers, T.; Kennedy, C.; Chiew, Y.-E.; Berchuck, A.; MacGregor, S.; Pharoah, P. D. P.; Goode, E. L.; deFazio, A.; Webb, P. M.; Chenevix-Trench, G. (American Association for Cancer Research (AACR), 2015)
      PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypothesize that germline polymorphisms might be associated with clinical outcome. EXPERIMENTAL DESIGN: We analyzed ...